Akums Drugs and Pharmaceuticals (NSE:AKUMS) Construction In Progress: ₹2,013 Mil (As of Mar. 2026)


NSE:AKUMS Akums Drugs and Pharmaceuticals Ltd NSE:AKUMS
40 GF Score
Price ₹658.20
! 7 Warning Signs
View Full Analysis

What is Akums Drugs and Pharmaceuticals Construction In Progress?

Akums Drugs and Pharmaceuticals NSE:AKUMS -0.38% 40 Construction In Progress is ₹2,013 Mil as of Mar. 2026. GuruFocus rates NSE:AKUMS with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

Akums Drugs and Pharmaceuticals's quarterly construction in progress declined from Sep. 2025 (₹1,581 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹2,013 Mil).

Akums Drugs and Pharmaceuticals's annual construction in progress declined from Mar. 2024 (₹2,086 Mil) to Mar. 2025 (₹1,735 Mil) but then increased from Mar. 2025 (₹1,735 Mil) to Mar. 2026 (₹2,013 Mil).

Akums Drugs and Pharmaceuticals Construction In Progress Historical Data

* Premium members only.

The historical data trend for Akums Drugs and Pharmaceuticals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akums Drugs and Pharmaceuticals Construction In Progress Chart

Akums Drugs and Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial 468.50 1,227.96 2,085.73 1,734.72 2,012.66

Akums Drugs and Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,734.72 0.00 1,581.05 0.00 2,012.66
NSE:AKUMS
40GF Score
Akums Drugs and Pharmaceuticals Ltd NSE:AKUMS
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akums Drugs and Pharmaceuticals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹2,013 Mil mean?
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a Construction In Progress of ₹2,013 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Akums Drugs and Pharmaceuticals and its competitors.
Is Akums Drugs and Pharmaceuticals' Construction In Progress too high?
Akums Drugs and Pharmaceuticals' current Construction In Progress is ₹2,013 Mil. Overall, Akums Drugs and Pharmaceuticals has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Akums Drugs and Pharmaceuticals' Construction In Progress compare to ZTS and UTHR?
Akums Drugs and Pharmaceuticals' Construction In Progress of ₹2,013 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Akums Drugs and Pharmaceuticals and its competitors. Akums Drugs and Pharmaceuticals's current Construction In Progress is ₹2,013 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akums Drugs and Pharmaceuticals stock overvalued right now?
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a current Construction In Progress of ₹2,013 Mil. The current Construction In Progress is ₹2,013 Mil. Akums Drugs and Pharmaceuticals' overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Akums Drugs and Pharmaceuticals (NSE:AKUMS), the current Construction In Progress is ₹2,013 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Akums Drugs and Pharmaceuticals Business Description

Other Exchanges 544222:India
Address Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). It operates in five segments: Contract Development and Manufacturing Operations, Active Pharmaceutical Ingredient (API), Domestic Branded formulations, International Branded Formulations, and Trade generics. Key revenue is generated from Contract Development and Manufacturing Operations.
40GF Score

Get the complete analysis for NSE:AKUMS

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹658.20
Price